Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDivestmentsFree Cash FlowNet Cash FlowNet IncomeOther financing activities
Growth Metrics
Income Statement
Others
Ratios

Genoil (GNOLF) Gains from Investment Securities (2021 - 2024)

Historic Gains from Investment Securities for Genoil (GNOLF) over the last 4 years, with Q4 2024 value amounting to $835.4 million.

  • Genoil's Gains from Investment Securities rose 784.26% to $835.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was $835.4 million, marking a year-over-year increase of 784.26%. This contributed to the annual value of $835.4 million for FY2024, which is 784.26% up from last year.
  • Genoil's Gains from Investment Securities amounted to $835.4 million in Q4 2024, which was up 784.26% from $774.6 million recorded in Q4 2023.
  • In the past 5 years, Genoil's Gains from Investment Securities registered a high of $835.4 million during Q4 2024, and its lowest value of $608.3 million during Q4 2021.
  • Moreover, its 4-year median value for Gains from Investment Securities was $706.6 million (2022), whereas its average is $714.2 million.
  • As far as peak fluctuations go, Genoil's Gains from Investment Securities surged by 498.28% in 2022, and later skyrocketed by 2129.91% in 2023.
  • Quarter analysis of 4 years shows Genoil's Gains from Investment Securities stood at $608.3 million in 2021, then grew by 4.98% to $638.6 million in 2022, then rose by 21.3% to $774.6 million in 2023, then increased by 7.84% to $835.4 million in 2024.
  • Its last three reported values are $835.4 million in Q4 2024, $774.6 million for Q4 2023, and $638.6 million during Q4 2022.